Lenz G, Hawkes E, Verhoef G, Haioun C, et al. Correction: Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma. Leukemia 2024 Jan 10. doi: 10.1038/s41375-023-02133.
PMID: 38200221